Endoscopic balloon dilatation in pediatric patients with esophageal strictures: From the past to the future

Following its first successful use in re-opening an artery with stenosis by Dr. Andreas Gr üntzig in 1974,1 balloon catheter was applied to not only angioplasty but also dilatation of esophageal strictures under fluoroscope in two adults in 1981 and under fiberesophagoscope in seven patients, including a child with caustic stricture complicated twice with perforation in 1984.2,3 Balloon catheters can pass thorough severe, lengthy, irregular esophageal strictures with a bendable guide wire with subsequent balloon catheter dilatation for patients who had failed treatment with conventional bougienage techniques.
Source: Pediatrics and Neonatology - Category: Perinatology & Neonatology Authors: Tags: Editorial Source Type: research

Related Links:

AbstractPurpose of reviewPaclitaxel-based endovascular devices have become the standard of care in symptomatic, medication-refractory peripheral artery disease (PAD) and in critical limb ischemia (CLI). This review examines the data on the efficacy and safety of these devices relative to standard balloon angioplasty (PTA) and bare metal stents (BMS).Recent findingsRandomized controlled trials (RCTs) have found that peripheral devices coated with paclitaxel result in superior patency rates and decreased target lesion revascularization (TLR) compared with non-drug-coated devices. Recently, a meta-analysis of randomized contr...
Source: Current Treatment Options in Cardiovascular Medicine - Category: Cardiology Source Type: research
Authors: Minatsuki S, Hatano M, Maki H, Takimoto E, Morita H, Komuro I Abstract Current therapeutic methods for chronic thromboembolic pulmonary hypertension (CTEPH) can improve hemodynamic status and are expected to improve prognoses. However, some patients experience dyspnea during effort and continue supplemental oxygenation despite their hemodynamic status being fully improved. Considering the pathogenesis of CTEPH, the dead space and intrapulmonary shunt are assumed to be responsible for hypoxia in CTEPH, but their contributions are unclear. It is also unclear whether they are improved after treatment. The aim...
Source: International Heart Journal - Category: Cardiology Tags: Int Heart J Source Type: research
This article describes less-invasive endovascular alternatives, such as atherectomy, drug-coated balloons and stenting, and their results. The popliteal artery is also difficult to treat in an endovascular manner due to biomechanical forces during bending and stretching of the knee or leg. Thus, we also describe currently available minimally invasive treatment options for the popliteal artery. PMID: 31476793 [PubMed - as supplied by publisher]
Source: Surgical Technology International - Category: Surgery Tags: Surg Technol Int Source Type: research
ConclusionIndividualized endovascular treatment strategy for selected patients with acute VBAO could achieve satisfactory reperfusion rate and favorable prognosis.
Source: Neuroradiology - Category: Radiology Source Type: research
Concept Medical’s MagicTouch AVF might have the “magic touch” when it comes down to nabbing breakthrough device designations. The proposed indication for the latest breakthrough device designation is for the treatment of stenotic lesions of Arteriovenous Fistulae or Arteriovenous graft in the hemodialysis treatment of renal failure. Concept Medical said its first pilot study to investigate the safety and efficacy of Magic Touch PTA Sirolimus balloon was started in Singapore in 2018. Led by Principal Investigator, Dr. Tan Chieh Suai, a multi-disciplinary team of doctors ...
Source: MDDI - Category: Medical Devices Authors: Tags: Cardiovascular Source Type: news
No abstract available
Source: Journal of Hypertension - Category: Cardiology Tags: EDITORIAL COMMENTARIES Source Type: research
ConclusionIVC rupture is a rare complication of PTA treatment of BCS and most commonly located at the intra-hepatic IVC caused by oversized balloons which does not require additional treatment.
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research
This study intended to assess effectiveness and safety of the drug-coated balloon (DCB) angioplasty of infrapopliteal atherosclerotic lesions in patients with critical limb ischaemia (CLI) in a real-world setting.MethodsConsecutive patients with critical limb ischaemia who underwent infrapopliteal drug-coated balloon angioplasty with the ELUTAX SV DCB were enrolled into the prospective, multicentre, single-arm observational registry. Primary outcome was clinical improvement at 6 and 12  months. Secondary outcomes were change in quality of life, primary patency, freedom from repeat revascularisation, and amputation-fre...
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research
Publication date: Available online 27 August 2019Source: Journal of Vascular and Interventional RadiologyAuthor(s): Yanhua Zhen, Zhihui Chang, Chuanzhuo Wang, Zhaoyu Liu, Jiahe ZhengAbstractSystematic literature searches using Embase, PubMed, and Cochrane Library for directional atherectomy with antirestenotic therapy (DAART) in femoropopliteal artery disease (FPAD) from January 2003 to February 2018 were conducted to evaluate clinical safety and effectiveness. A meta-analysis was conducted using Stata software for the event rate of technical success, bailout stent placement, primary patency, and target lesion revasculariz...
Source: Journal of Vascular and Interventional Radiology - Category: Radiology Source Type: research
ConclusionsFTTP, as presented herein, appears to be a safe, effective, and cost-effective technique in the resolution of acute IFDVT.
Source: Journal of Vascular Surgery: Venous and Lymphatic Disorders - Category: Surgery Source Type: research
More News: Angioplasty | Baloon Angioplasty | Children | Pediatrics | Perinatology & Neonatology